Shares of Spire Healthcare Group PLC (LON:SPI) have earned an average recommendation of “Hold” from the nine analysts that are covering the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 352.56 ($4.44).
Several research firms have commented on SPI. Berenberg Bank reissued a “buy” rating and set a GBX 360 ($4.53) price objective on shares of Spire Healthcare Group PLC in a report on Wednesday, April 12th. Numis Securities Ltd reaffirmed an “add” rating and issued a GBX 370 ($4.66) price target on shares of Spire Healthcare Group PLC in a report on Tuesday, April 4th. JPMorgan Chase & Co. lowered their price target on shares of Spire Healthcare Group PLC from GBX 433 ($5.45) to GBX 376 ($4.73) and set a “neutral” rating for the company in a report on Friday, March 10th. Morgan Stanley reaffirmed an “equal weight” rating and issued a GBX 350 ($4.41) price target on shares of Spire Healthcare Group PLC in a report on Monday, March 20th. Finally, Liberum Capital reaffirmed a “buy” rating and issued a GBX 400 ($5.03) price target on shares of Spire Healthcare Group PLC in a report on Thursday, March 2nd.
In related news, insider Simon Gordon sold 58,539 shares of the stock in a transaction dated Thursday, March 30th. The shares were sold at an average price of GBX 328 ($4.13), for a total value of £192,007.92 ($241,671.39).
Spire Healthcare Group PLC (LON:SPI) traded down 1.05% during midday trading on Monday, reaching GBX 321.40. The company had a trading volume of 509,072 shares. The company’s market capitalization is GBX 1.29 billion. The firm has a 50-day moving average price of GBX 327.48 and a 200-day moving average price of GBX 343.11. Spire Healthcare Group PLC has a 52 week low of GBX 295.00 and a 52 week high of GBX 411.00.
The firm also recently declared a dividend, which will be paid on Tuesday, June 27th. Investors of record on Thursday, June 1st will be issued a GBX 2.50 ($0.03) dividend. This is an increase from Spire Healthcare Group PLC’s previous dividend of $1.30. The ex-dividend date is Thursday, June 1st. This represents a dividend yield of 0.75%.
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065535/spire-healthcare-group-plc-spi-receives-gbx-352-56-consensus-target-price-from-brokerages.html
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.